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Introduction: What is cellular agriculture?
Cellular agriculture is an emergent field in which agricultural 
products—most typically animal-derived agricultural products— 
are produced through processes operating at the cellular 
level, as opposed to (typically farm-based) processes operating 
at the whole-organism level. This review details the cellular 
agriculture landscape in the UK at the time of publishing, 
providing an overview of key actors in the sector from a range 
of backgrounds, including university and corporate laboratory 
research, private investors, social science, Life Cycle Analyses, and 
policy work.
The term cellular agriculture was first coined in 2015 by Isha 
Datar, Executive Director of US-based 3rd sector group New 
Harvest. Potential future products bracketed under the label 
cellular agriculture include meat produced though tissue 
engineering (variously known as cultured meat, clean meat, 
cell-based meat and cultivated meat (referred to herein as 
CM)), and animal-derived products such as milk, leather and 
egg white produced through recombinant DNA fermentation 
techniques (Datar et al., 2016; Stephens et al., 2018). As 
these examples suggest, cellular agriculture is typically 
divided into two types, based on the technology form used. 
The first has been called ‘tissue engineering-based cellular 
agriculture’ (Stephens et al., 2018) and involves taking cells 
from live (or recently deceased) animals and culturing these 
cells so as to control their cell proliferation and differentiation to 
direct the formation of increasing quantities of a desired cell 
type (e.g. muscle and fat for meat, skin for leather). The 
second has been termed ‘fermentation-based cellular agricul-
ture’ (ibid) and involves genetically modifying typically bacteria, 
yeast or algae by adding recombinant DNA so that when they 
are fermented in sugars they produce organic molecules that 
can subsequently be processed to biofabricate familiar products 
such as milk and leather.
While the term cellular agriculture is less than five years old, 
the technologies it describes have a longer history. In terms of 
tissue engineering-based cellular agriculture, the first work 
to increase the mass of in vitro muscle under laboratory 
conditions happened around the millennium (Benjaminson 
et al., 2002; Catts & Zurr, 2002), with further work in the 
following decade (Puy et al., 2010; Wilschut et al., 2008). In 
terms of fermentation-based cellular agriculture, some suggest 
the historical lineage can be drawn as far back as industrially- 
produced rennet used in manufacturing cheese, which has 
used recombinant DNA techniques since the 1990s to replace 
enzymes taken from ruminant mammals, typically after their 
slaughter. However, manufacturers using this technique have not 
adopted the term cellular agriculture and do not feature within 
the emergent cellular agriculture community, so we do not include 
rennet in our review. Similarly, some products that are naturally 
produced in plants can be made using fermentation, such as 
flavour molecules and oils like vanilin, but these have not 
generally be classed as cellular agriculture to date. It could be 
argued that they fall under the same umbrella if their goal is the 
same (i.e. sustainable production), as is the case of the palm oil 
substitute discussed later.
The call for cellular agriculture is generally motivated by a set 
of related concerns about the impacts of animal agriculture as it 
exists today and the challenges of the increased global popula-
tion in the coming decades. Cellular agriculture can be said to be 
directed at addressing UN Sustainable Development Goal Two 
(Zero Hunger) and Goal Twelve (Responsible Consumption 
and Production). While the exact form the potential contribution 
of cellular agriculture may take varies from case to case, the recur-
rent themes are a concern with the environmental impact of 
animal agriculture (in terms of land use, greenhouse gas emissions, 
impact on biodiversity etc., see Bhat et al., 2015, Mattick, 2018), 
as well as animal ethics concerns about livestock living condi-
tions and slaughter (Milburn, 2018; Schaefer & Savulescu, 2014), 
and the impact on human health of animal agriculture through 
issues such as animal-borne disease and antibiotic use (Arshad 
et al., 2017; Specht et al., 2018). The view is that cellular 
agriculture will allow the continued production of familiar 
animal products while using either fewer or no animals in the 
process. The aim is that this would result in either reducing (or 
entirely replacing) animal agriculture, or that it would slow the 
increase in global use of animals in agriculture to meet global 
rising demand for animal products driven by population and 
wealth increases. This given, while there is optimism within the 
community, a number of substantial technical hurdles remain 
(Stephens et al., 2018; Thorrez & Vandenburgh, 2019).
In this review we suggest the common-use definition of cellular 
agriculture could be expanded to also include the cellular 
production of agricultural goods that are not sourced from 
animals, here reflecting upon the example of fermentation-
based palm oil production (an active area of research in the UK). 
Intuitively this makes sense, as this fermentation-based work is 
producing agricultural products at the cellular level. This work 
also ties to typical environmental and animal welfare concerns 
expressed elsewhere within the cellular agriculture community. 
However, at this stage, we raise this as just a possibility, and do 
not seek to assert a new definition upon the field.
Global context
The leading nations in cellular agriculture today arguably are the 
US, the Netherlands, and Israel, although work is conducted in 
numerous other countries, including the UK. In terms of CM, the 
first larger scale project was conducted in the Netherlands from 
2005 onwards. One member of this initial consortia, Prof Mark 
Post of Maastricht University, went on to secure funding from 
Google co-founder Sergey Brin to produce the world’s first 
laboratory-grown hamburger, which was cooked and tasted at 
a press conference in London in 2013 (O’Riordan et al., 2017; 
Post, 2014). The interest this generated fed into a change of 
culture within the international CM community, as the first 
10–15 years of largely university-based research shifted towards 
the emergence of a start-up culture (Stephens et al., 2019). While 
University research has continued, the focus has shifted to the 
swiftly increasing number of early stage companies in the area, 
seeking and securing venture capital seed funding for their 
work. Among the highest profile in the US are Memphis Meats, 
who were the first CM company to secure series A funding of 
$17m, and the vegan-mayonnaise and liquid egg company Just 
Page 3 of 16
Wellcome Open Research 2020, 5:12 Last updated: 14 FEB 2020
(formally Hampton Creek) who have also established a CM 
R&D initiative. Others include Mission Barns, Wild Type, and 
Bluefin tuna-focused Finless Foods. Outside of the US, the 
Netherlands has remained a key site with Post following his burger 
press conference with the establishment of a start-up, Mosa Meat, 
which in 2018 announced a funding round of €7.5m. A second 
company, Meatable, also runs out of Leiden. Israel also has a 
strong base, with companies including Future Meat Tech-
nologies and Aleph Farms, who recently completed a funding 
round of $11.65m. Other examples include Japan-based Integ-
riculture, Singapore-based Shiok Meats, and Canada-based 
Appleton Meats. As private entities, it is not always clear 
exactly what proprietary technology each company is developing, 
or how advanced their technology is.
In terms of fermentation-based cellular agriculture, the inter-
national context is dominated by US companies, particularly 
those based in the San Francisco Bay area. Key examples include 
Geltor, who produce gelatin, Clara Foods, who produce egg 
white, and both Perfect Day and New Culture, who produce 
animal-free dairy products. Outside of California, the most 
prominent company is Modern Meadow, who ferment collagen 
to use in manufacturing leather-like products. Modern Meadow 
were initially the first company to work on CM, but later 
focused exclusively on leather. Beyond the US, the main example 
would be Japan-based Spiber, who make spider silk. Further 
information on the global context can be found in State of the 
Industry Reports for CM and plant-based meats, eggs and dairy 
from the Good Food Institute.
Review methodology
This review is rooted in a ten-year social science project 
conducted by N.S. This project has involved over 50 interviews 
with experts internationally in CM, as well as attendance at key 
meetings and media analysis of reporting on the subject. N.S. 
and M.E. are part of a group that co-founded an organisation 
named ‘Cultivate’ in 2016 to act as a multi-voiced forum 
for discussing issues around cellular agriculture in the UK. 
Cultivate organises an annual event to bring together the UK 
cellular agriculture community. During its November 2018 
event a draft document produced by N.S. on UK activity in this 
area was circulated and commented upon by those present. 
After this, N.S. followed up the suggestions made in that 
discussion and conducted further desk-based research and 
direct contact with groups involved to develop the work reported 
here. This exercise was addressed again during Cultivate event in 
November 2019 to up-date and finalise the review.
As noted above, cellular agriculture is an emerging field, and 
much of the leading research has been conducted within private 
companies that do not typically publish their research. As such, 
this review includes fewer references to peer-reviewed sources 
than would be the case in a typical review article. This is by 
necessity, as there are only a limited number of peer-reviewed 
papers available on this novel area of research. Subsequently this 
review combines references to peer-reviewed research with grey 
literature found in reports, institutional websites, and media 
reporting.
We note that we ourselves are among the most active in this 
field in the UK, and as such we review our own work as part 
of this text. We also note that cellular agriculture can some-
times seem a fast moving field, with new entrants appearing 
frequently. Often in the commercial sphere such entities operate 
in what is termed ‘stealth mode’, to indicate a low profile. As 
such, it is possible our account may miss some UK activity, 
and can only claim to capture the context as we know it to be at 
the time of publication.
Cellular agriculture-related work in the UK
Histories of cellular agriculture often include two key 
UK-related components, both related to CM. The earliest is a 
regularly repeated quotation from Winston Churchill in a 1931 
article titled ‘Fifty Years Hence’, in which he states “[w]e shall 
escape the absurdity of growing a whole chicken in order to eat 
the breast or wing, by growing these parts separately under a 
suitable medium” (Churchill, 1931). Typically, people from the 
community follow the quotation by noting it is taking longer 
than Churchill predicted, but the trajectory was correct. The 
second UK-related historical milestone is the 2013 London 
press conference in which Post and his team at Maastricht 
University unveiled the world’s first cultured burger, which 
had been grown in his laboratory in the Netherlands and 
transported to the UK just before. The burger was a proof of 
concept as opposed to a product launch, as it was reported to 
have cost around $300,000. It was tasted by two independent 
food journalists from Austria and the US, after being cooked 
by chef Richard McGeown, patron of Couch’s Great House 
Restaurant in Cornwall, UK (O’Riordan et al., 2017; Post, 2014).
In the following sections we review key aspects of UK cellular 
agriculture activity, focusing upon different clusters of activity 
in turn.
University laboratory research
The most active university in the UK is the University of Bath. 
Dr Marianne Ellis and Dr Chris Chuck are the bioprocessing 
strand lead and director, respectively, in the Centre for Integrated 
Bioprocessing Research (CIBR). The Ellis group focuses on 
tissue engineering-based cellular agriculture; the Chuck group 
focuses on fermentation-based cellular agriculture, specifically 
production of a palm oil substitute from yeast. Ellis began her 
research career in regenerative medicine and has applied her 
bioprocess design techniques to the expansion of muscle 
cells for CM. Given her experience with in vitro liver models 
(Luetchford et al., 2018; Storm et al., 2016) and her early-
career work on scaffold development for mesenchymal stem cell 
expansion (Morgan et al., 2007), she has positioned herself to 
develop platform technologies for a wide range of tissue engi-
neered cellular agriculture products, specifically based around 
scalable bioreactor design (Allan et al., 2019). She has a research 
group, with funding from New Harvest amongst others, devel-
oping bioreactors and scaffolds for CM, and gives Chemical 
Engineering undergraduate students the opportunity to carry 
out major project work in this space, having now supervised 
over 30 Masters of Engineering student projects on the topic of 
cultured meat bioprocess design. The work combines tissue 
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engineering with established biotechnology process design 
with the addition of novel approaches to scaling up tissue 
engineering cultures. Focus is on bioreactor configuration; 
given the early stage of this work, much effort is going into 
understanding the metabolic stoichiometry, i.e. how much raw 
material is consumed by the cells to produce a given amount of 
protein as well as the waste products. This is intimately linked to 
efficient scale up due to it being the basis for media recipes 
and amounts required, which is likely to be affected by cell type 
and culture conditions.
Aberystwyth University has recently started working on cellular 
agriculture via a PhD student co-funded by M.E.’s start-up, 
Cellular Agriculture Ltd, the Institute of Biology, Environment 
and Rural Sciences (IBERS) at Aberystwyth University and 
the Pedigree Welsh Pig Society. The project is examining cell 
sourcing and harvest for cultured pig meat. To our knowledge 
this is the first and only study in the world exploring the 
properties of primary porcine cells to find the most efficient 
for CM production. This type of research is commonplace in 
traditional meat production, albeit for the whole animal, and it 
follows that there will be particular breeds whose cells are more 
conducive to the bioreactor culture environment than others, 
thus leading to a more efficient production process, like the 
broiler chicken, and even a customer-preferred source likened to 
prime cuts of meat like Aberdeen Angus beef.
Also, in 2019, US-led third sector group the Good Food Insti-
tute provided $210,088 funding to Petra Hanga, lecturer in 
Biological Engineering at Aston University, to work on bio-
processing and scale-up. Her focus is upon microtissues com-
posed of fat and muscle in a scalable bioreactor platform. Working 
with bovine mesenchymal stem cells, the project aims to optimise 
protocols for increased cell production.
From 2018 until late 2019, US-based third sector group New 
Harvest have also been funding Dr Ricardo M. Gouveia at 
Newcastle University to investigate how substrate curvature 
effects the migration, proliferation and self-organisation of 
cells within a matrix, and how controlling this could support 
targeted bio-fabrication of tissues that reproduce the texture of 
meat. This work is based within the lab of Prof Che J. Connon, 
which is also connected to the start-up CellulaREvolution 
discussed in the next section.
Returning to the University of Bath, and moving away from 
CM, Chuck has been working on the scale up of oleaginous 
yeasts grown on waste resources for the production of a palm oil 
substitute (Parsons et al., 2018; Whiffin et al., 2016). Funded 
by a £3.9m grant from the EPSRC and Innovate UK, this MP² 
Project is a collaboration between the University of Bath, 
University of York, Croda, and AB Agri. They seek to create a 
sustainable biorefinery that uses food waste biomass that has 
been broken down with a one-step and additive-free microwave 
technology to hydrolyse the materials into fermentable sugars. 
Then, using oleaginous yeast as a platform mechanism, the MP² 
Project group seek to develop a pilot-industrial scale bioreac-
tor to produce larger quantities of single cells oils that can oper-
ate as a palm oil substitute for some purposes. Their current 
research involves optimising the yeast strain being used, and 
assessing the mechanics and economics of a scale-up system. 
The long-term goal is to produce a palm oil substitute—the 
world’s most widely used oil crop—with a system involving less 
deforestation and the associated habitat destruction.
Finally, moving away from food but remaining with cellular 
agriculture, in 2019 an Engineering and Physical Sciences 
Research Council-funded PhD project commenced at the Uni-
versity of Manchester. Supervised by Dr Celina Jones, Dr Olga 
Tsigkou and Dr Lucy Bosworth, the project aims to pair a 
synthetic scaffold with 3D cell culture techniques to produce a 
new uniformed textile-cell construct, or ‘leather’. The vision is to 
enable traditional fibre-scaffolds to be transformed into unique 
fabrics using textile processes. These biodegradable fabrics 
would then be cultured with fibroblasts, which should secrete 
extracellular matrix proteins (including collagen and elastin), 
and eventually be modified to be comparable to the dermis layer 
of the skin. This ‘artificial’ skin would then be subjected to 
traditional tanning processes, minus a number of previously 
essential steps, in an attempt to create a mechanically stable, 
uniform leather material.
Companies
The most visible CM company in the UK is Higher Steaks, 
founded by Benjamina Bollag (CEO), Dr Stephanie Wallis (CSO), 
and Prof David Hay (Scientific Director) in 2017. Higher Steaks 
is a ‘full stack’ company, meaning its focus is upon producing 
a consumer ready CM product, as well as working on all the 
intermediary steps in a vertically integrated form. They are 
developing a technology that could use skin biopsies or blood 
samples from pigs to which an induced pluripotency technique 
is applied to create cells that could produce any type of tissue 
including muscle and fat for use in pork products. Pork has 
been chosen as the initial focus as porcine biology is close to 
human biology, allowing biomedical insights to be more eas-
ily translated, and because of Higher Steaks’ concern that pigs 
in the meat industry have a higher exposure to antibiotics than 
cattle. However, they also expect their technology to be appli-
cable to other species in the future. Like many full stack CM 
start-ups, they are also working to develop methods for reduc-
ing the cost of the media in which their cells are grown, as media 
is the highest costing input to the process. On this, they have 
already established culturing protocols that work sufficiently 
well without fetal bovine serum (an animal-derived blood 
product), but are continuing research efforts in this area. In 
mid-2019, the team was made up of Bollag and Wallis and a stem 
cell scientist, while Hay contributed in parallel to his role as the 
chair of the Tissue Engineering department at MRC Centre for 
Regenerative Medicine at the University of Edinburgh. They also 
have a team of advisors. Higher Steaks raised a pre-seed round 
and are currently preparing for their seed round and anticipate 
expanding once further capital is secured.
While Higher Steaks have been more visible, the first CM 
company to be established in the UK was Cellular Agriculture 
Ltd, founded in 2016 by Illtud Dunsford and Ellis. The com-
pany is in some regards distinct internationally: co-founder 
Dunsford’s background is in farming as the owner of a successful 
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meat production and processing business set on the family farm 
of 300 years (Charcutier Ltd), giving the company an unusual 
grounding in traditional meat production. Cellular Agriculture 
Ltd has not adopted a ‘full stack’ business model and does not 
seek to produce meat themselves. Instead they are commercial-
ising the bioprocess with focus on the bioreactor technology, 
developed in the Ellis laboratory at the University of Bath, to 
enable the industry to manufacture their products on a commer-
cial scale. The company is leveraging its university contacts, 
and co-funds two PhD students alongside US-based 3rd sector 
group New Harvest and the University of Bath for bioreactor 
design, and Aberystwyth University for cell sourcing and 
harvesting. It has also developed its own proof of concept 
bioreactor via InnovateUK funding. In mid-2019 they were 
preparing their seed round.
There have been, and continue to be, other companies with 
UK links active in the field. CellulaREvolution Ltd are a new 
spin out company from Newcastle University co-founded by Leo 
Groenewegen CEO, Dr Martina Miotto CSO and Prof. Che 
Connon CTO. The team work with peptides for multiple purposes. 
This includes developing methods for continuous bioprocess-
ing in which cells automatically self-detach from their growing 
surface to allow other cells to subsequently grow in the same 
space. This substantially increases production yields, all within 
a serum-free environment whilst reducing media volume and 
footprint (Miotto et al., 2017). Their research was originally 
developed for medical uses, particularly the cornea, but they 
are now exploring applications in both biomedicine and CM 
(CellulaREvolution, 2018). In November 2019, CellulaREvolution 
announced a £380,000 investment via the North East Angel 
R&D programme, managed by Northstar Ventures.
Also recently established, Multus Media are seeking to produce 
animal-free, sustainable and cheap media for the CM industry. 
Their approach is to use genetically engineered yeast to produce 
mammalian cell growth factors. Based out of Imperial College 
Advanced Hackspace (ICAH) in London, the project is led by 
Kevin Pan with a team of 13 other scientists.
Another start-up, Biomimetic Solutions, is also exploring 
developing enabling technologies with applications in both 
CM and biomedicine. Starting in Brazil, the company moved to 
London in 2018 and participated in the RebelBio accelerator 
programme. Currently Biomimetic Solutions retains links to 
both Brazil and the UK. They have patented a scaffold called 
Nano3D that is edible and pH neutral that could provide a 
framework for muscle cells to grow into as CM is produced. The 
scaffold has been trialled by US CM company Finless Foods 
(Benz, 2018).
Private investors
The most active private funder of cellular agriculture work in 
the UK is CPT Capital, a dedicated investor in the alternative 
protein sector. It is run through the family office of Jeremy 
Coller, a successful financial executive. They have invested in both 
plant-based proteins (including famous names like Beyond Meat 
and Impossible Foods) as well as a string of cellular agriculture 
companies, including Geltor (gelatine), Perfect Day and New 
Culture (both dairy products), Modern Meadow and Vitro Labs 
Inc (both leather), and Blue Nalu, Aleph Farms, Memphis Meats, 
and Mosa Meat (all CM). While these are largely US-based 
companies, CPT Capital are now “looking to expand the geo-
graphic representation” of their portfolio. They look for pre-
seed to Series B stage companies with a view to long-term 
support.
The second most active investor in the sector that we are 
currently aware of is Agronomics Limited, who focus specifi-
cally on nascent modern foods that target environmental benefits. 
Their listed investments include BlueNalu, New Ages 
Meats, Shiok Meats and Meatable. Other single company 
investments from the UK include Atomico’s investment 
in Memphis Meats, Backed VC’s investment in the Dutch com-
pany Meatable, and Breakoff Capital’s investment in Finless 
Foods. Other UK-related investors include Richard Branson, 
who famously invested in Memphis Meats Series A round, and, 
as reported above, biotech incubator RebelBio (backed by glo-
bal venture capital firm SOSV), who supported Biomimetic 
Solutions.
Social science
The UK has a strong portfolio of work in social science analyses 
of cellular agriculture. The earliest was an economic forecast 
produced by eXmoor pharma concepts (2008), which predicted 
CM could be produced for €3300-3500 per tonne, compared 
to about €1800 per tonne for chicken meat. At this time, sociolo-
gist Dr Neil Stephens began an extended project, still continuing 
today, tracking the long-term development of CM and the 
community that supports it. His early work identified the 
ontological ambiguity over what CM actually is—as meat, or 
as meat alternative, or even not as food at all—and has subse-
quently documented the technical and cultural moves that have 
sought to define its status and politics (O’Riordan et al., 
2017; Stephens, 2010; Stephens, 2013; Stephens & Ruivenkamp 
2016; Stephens et al., 2018; Stephens et al., 2019). Continuing 
the interdisciplinary theme, lawyer Dr Ludivine Petetin (2014), 
then of the University of Hull, published work arguing EU 
regulation needed strengthening in response to CM. Bioethicists 
Dr Owen Schaefer and Prof Julian Savulescu (2014), then of the 
University of Oxford, argued CM is permissible and worth 
promoting. 2014 also saw the first UK academic meeting 
dedicated largely to CM. Titled ‘The Ethics of In-Vitro Flesh 
and Enhanced Animals’ and hosted in the small Northumberland 
Town of Rothbury, the two-day event featured a range of 
social science papers addressing the issue. One attendee was 
geographer Dr Alexandra Sexton, now of the University of 
Oxford, who has gone on to analyse the political framing of CM 
as edible, and transformative, technology (Sexton, 2016; Sexton, 
2018; Sexton et al., 2019). Over the next couple of years, a 
number of reports on public perceptions of CM were published, 
first by an international group including staff at the University 
of Bath (Marcu et al., 2015), and then by a group at the Tyndall 
Centre for Climate Change Research at the University of 
Manchester (O’Keefe et al., 2016). More recently, Christopher 
Bryant, working with the Bath group, has published a further 
set of survey-based consumer analyses (Bryant & Barnett, 2018; 
Bryant & Barnett, 2019; Bryant et al., 2019), and a group at 
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Harper Adams University, led by Frank Vriesekoop are doing 
similar work (see Gómez-Luciano et al., 2019). Recently, 
Dr Josh Milburn, of the University of Sheffield, has also written 
supportively on the ethics of cultured meat and milk (Milburn, 
2016; Milburn, 2018), while John Miller, also of the University 
of Sheffield is writing on the literary history of CM (Miller, 
2019).
Environmental life cycle analyses
Life cycle analyses (LCA) assess the environmental impact 
across the lifecycle of a particular product or output. Such work 
has inherent difficulties in the context of cellular agriculture as 
the products being modelled are still early in their research and 
development process, and have not yet entered scale-up processes. 
As such LCAs on the topic involve making multiple assump-
tions, or the use of the closest real-world example in the absence 
of empirical material on actual cellular agriculture processes. 
However, potential environmental benefits are key motivators 
for many cellular agriculture products, so a number of attempts 
have been made to quantify what this benefit would be. Three of 
these have been produced in the UK. The earliest of these was the 
first LCA of CM produced anywhere in the world, by Dr Hannah 
Tuomisto, then of Oxford University, working with Dr Joost 
Teixeira De Mattos of the University of Amsterdam. As well 
as the first, this LCA has to date remained the most optimistic, 
suggesting that compared to conventionally produced European 
meat, a CM system could result in 7–45% lower energy use, 
78–96% less greenhouse gas emissions, 99% lower land use, 
and 82–96% lower water use (Tuomisto & de Mattos, 2011). 
Four years later, Dr Mark Steer of the University of the West of 
England conducted an LCA of milk produced through cellular 
agriculture, based on the work of San Francisco start-up Muufri 
(now Perfect Day). The modelling here found Muufri’s milk could 
use 35% of the energy, 16% of the greenhouse gases, 1% of the 
land and 2% of the water compared to the conventional dairy 
industry (Steer, 2015). Finally, more recently in 2019, another 
Oxford University group published an LCA of CM compar-
ing a wider set of potential production and use contexts than 
previous work, and looked across multiple timeframes, up until 
1,000 years in the future. The study found that, while in many 
instances CM is climatically superior to conventional livestock 
production, some scenarios may exist in which this is not the case 
(Lynch & Pierrehumbert, 2019).
3rd sector groups, charities and think tanks
There are two dedicated UK-based third sector groups in the 
UK, as well as UK representation of international (generally 
US-based) groups and a level of interest among UK third sector 
groups with a broader remit. The first dedicated UK third sector 
group was ‘Cultivate’, founded in 2016 by an interdisciplinary 
and cross-sector team of five (that include the authorship team of 
this review). It describes itself as “a multi-voiced forum intended 
to support informed dialogue about the emergent field of cellular 
agriculture from UK perspectives”. It formed after the group 
who went on to become its founders were invited to a number 
of discussions at 10 Downing Street about UK policy in this 
area, during which they produced a review of UK activity and 
a set of policy recommendations, one of which was to establish 
the networking group that became Cultivate. A significantly 
reedited version of their report went on to be published as 
Stephens et al., (2018). Cultivate have hosted an annual meeting 
since 2016 and produce written outputs on the topic.
A second dedicated UK third sector group was established in 
2018. ‘Cellular Agriculture UK’ seeks to “provide a clear, central 
hub and contact point for those who have independently 
developed interest in the space” and to “reach out to potential 
interested parties and support their engagement in the space” 
(Cellular Agriculture, 2018) and held their first activities in 
early 2019. Beyond these UK-based groups, three US based 
groups also have UK representation. The Cellular Agriculture 
Society have UK-based volunteers. The Good Food Institute 
now has a representative in the UK, having recently employed 
its first UK-based staff member, Richard Parr, as their Managing 
Director (EU); as noted previously, they have funded Hanga’s 
research at Aston University. Another leading US-based third 
sector group—New Harvest—fund PhD research at the Ellis lab 
at the University of Bath and Gouveia’s work at Newcastle 
University, as well as earlier work at King’s College London and 
the University of Oxford.
Additionally, a number of UK groups with broader focus have 
produced reports about CM, including the Adam Smith Institute 
(Hollywood & Pirie, 2018), the Food Ethics Council (2015) 
and the Nuffield Council on Bioethics (2019). Among the most 
detailed is a report by Chatham House (Froggatt & Wellesley, 
2019) that specifically articulates considerations for the EU. In 
particular, they raise issues relating to how regulation and 
labelling decisions made by policy-makers could frame future 
direction and pace of growth.
Conclusion
Cellular agriculture, both as a term and as a field of activity, 
remains relatively new. Those developing the technologies 
associate it with a range of significant benefits, but the tech-
nology remains early-stage in many cases, and the capacity 
of these technologies to deliver these benefits remains unknown 
and subject to the social context of their introduction. The 
technologies have garnered support over the last five years from 
a set of technology investors, often with links to Silicon Valley 
finances or modes of working. UK activity, in this context, is 
increasing but remains smaller than that found in countries such 
as the US, Israel and the Netherlands.
The longest-standing UK work has been university-based, 
although the number of companies has been growing in 
recent years. Unlike many of the American, Israeli and Dutch 
companies, all but one UK company have adopted a business-
to-business model, seeking to supply components necessary 
for CM production to other CM companies. The exception 
is Higher Steaks, who have adopted the full-stack model of 
seeking to produce marketable CM products. We also note that 
all of the UK companies are focused upon CM, with none of 
them addressing the broader set of cellular agriculture products. 
These companies are either seeking, or have gained, initial 
seed funding, but have attracted less finance than the leading 
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companies globally. Also notable is that the UK-based investors 
have most frequently directed their finance outside of the UK, 
primarily to the US, and have invested less domestically.
We have demonstrated that the UK has a long history of lively 
work on the social and policy aspects of cellular agriculture, 
covering key but diverse topics including the production of 
meaning, consumer responses, economics and regulatory 
analysis. This is not, we suggest, anything specific to cellular 
agriculture, but instead represents a strong UK portfolio of 
work on the analysis of emerging technologies in general. This 
academic work has fed into the emerging policy discussion, 
about how cellular agriculture should be regulated and what role 
it might have in society if realised as a commercial reality.
We detailed the two examples of UK cellular agriculture 
laboratory work beyond CM; the leather work and Manchester 
University and the MP² Project. As we noted, the MP² 
Project—focused upon a fermentation-based palm oil system—
demonstrates that cellular agriculture approaches need not be 
limited to animal-derived products and suggests that the com-
mon-use definition of cellular agriculture could be expanded to 
include non-animal agricultural products, including oils.
Overall, our review has shown that the UK is not the leading 
country in the world in cellular agriculture, but it does have 
an active and diverse community. Given the knowledge base 
within relevant fields in the UK, there is also significant 
potential for this body of work to increase in the coming years. 
We have provided this review to inform interested parties about 
who is active and what they are doing in the UK as 2020 
begins, both for the benefit of audiences keen to engage in 2020, 
and to record this moment of emergence for the historical 
record. The future of cellular agriculture is indeterminate, but it 
seems likely the UK will continue to be involved in the coming 
years.
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